Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia
2012 ◽
Vol 386
(2)
◽
pp. 155-166
◽
Keyword(s):
2008 ◽
Vol 378
(5)
◽
pp. 529-539
◽
2008 ◽
Vol 378
(5)
◽
pp. 515-528
◽
2015 ◽
Vol 138
◽
pp. 49-57
◽
Keyword(s):
2016 ◽
Vol 19
(Suppl_1)
◽
pp. 56-57
Keyword(s):
2019 ◽
Vol 128
◽
pp. 127-134
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 23
(5 and 6)
◽
pp. 603-608
◽